Skip to main content
SpringerLink
Log in

The need for community pharmacists in oncology outpatient care: a systematic review

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background One-third of all deaths in Europe each year are attributable to cancer. Issues relating to cancer care, therefore, will continue to expand. To manage the increased challenges—including doctor shortages, an ageing population, and rural distribution of supplies—community pharmacists will likely be required to assume responsibility within oncology care. Aim of the review To assess the need for further investigation into quantity and utility of community pharmacists’ interventions in assisting oncology outpatients. Methods Initial search terms for identifying relevant literature within the PubMed database were informed by four key questions. Study selection for the systematic review was performed based on inclusion and exclusion criteria, which were defined a priori using the PICO tool. Literature searches identified 2470 papers, for which titles and abstracts were reviewed. Of these, 220 papers were retained for detailed analysis. The full texts of these manuscripts were then screened by applying the inclusion criteria. The remaining 68 papers were included in the systematic review. Results Several models of pharmacists’ interventions in inpatient, medium, and outpatient care have proven to be successful, have been consistently efficacious, and have positively influenced patient outcomes. Importantly, the quantity of scientific research, and thus of reported beneficial outcomes, in outpatient care is much lower than that conducted for inpatient and medium care. Conclusion Based on our findings, we suggest that further investigation of community pharmacists’ interventions into oncology outpatient assistance is necessary, and that further research should be conducted to address this need.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Curtis LJ, McKinnon RA, Anderson C. Palliative care is everyone’s business, including pharmacists. Am J Pharm Educ. 2013;77(2):21.

    Article  Google Scholar 

  2. Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, et al. Delivering affordable cancer care in high income countries. Lancet Oncol. 2011;12:933–80.

    Article  PubMed  Google Scholar 

  3. Hoppe-Tichy T. Current challenges in European oncology pharmacy practice. J Oncol Pharm Pract. 2010;16:1.

    Article  Google Scholar 

  4. Tuffaha HW, Abdelhadi O, Omar SA. Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. Int J Clin Pharm. 2012;34:27–31.

    Article  PubMed  Google Scholar 

  5. Liekweg A, Westfeld M, Jähde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer. 2004;12:73–9.

    Article  PubMed  Google Scholar 

  6. Barth J, Baumann L, Bismarck C, Bornemann K, Braband S, Carstens G, et al. QuapoS4 Quality standard for the oncology pharmacy service with commentary. Onkopress, 2009.

  7. Chastek B, Harley C, Kallich J, Newcomer L, Paoli CJ, Teitelbaum AH. Health care costs for patients with cancer at the end of life. J Oncol Pract. 2012; 8(6s).

  8. Schickedanz A. Of value: a discussion of cost, communication and evidence to improve cancer care. Oncologist. 2010;15(1):73–9.

    Article  PubMed  Google Scholar 

  9. Fasola G, Aita M, Marini L, Follador A, Tossolini M, Mattioni L, et al. Drug waste minimization and cost containment in medical oncology: two-year results of a feasibility study. BMC Health Serv Res. 2008;8:70.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Session JK, Valgus J, Barbour SY, Iacovell L. Role of oncology clinical pharmacists in light of the oncology workforce study. J Oncol Pract. 2010; 6(5).

  11. Ise Y, Morita T, Katayama S, Kizawa Y. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan. J Pain Symptom Manage. 2014;47(3):588–93.

    Article  PubMed  Google Scholar 

  12. Avery M, Williams F. The importance of pharmacist providing patient education in oncology. J Pharm Pract. 2015;28(1):26–30.

    Article  PubMed  Google Scholar 

  13. Döhler N, Krolop L, Ringsdorf S, Meier K, Ko YD, Kuhn W, et al. Task allocation in cancer medication management—integrating the pharmacist. Patient Educ Couns. 2011;83(3):367–74.

    Article  PubMed  Google Scholar 

  14. Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013;21:1287–93.

    Article  PubMed  Google Scholar 

  15. Mancini R. Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic. J. Support Oncol. 2012;10:99–106.

    Article  PubMed  Google Scholar 

  16. Voll ML, Yap KD, Terpstra WE, Crul M. Potential drug–drug interactions between anti cancer agents and community pharmacy dispensed drugs. Pharm World Sci. 2010;32:575–80.

    Article  CAS  PubMed  Google Scholar 

  17. Bremberg E, Hising C, Nylen U, Ehrsson H, Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract. 2006;12(2):75–81.

    Article  PubMed  Google Scholar 

  18. Liekweg A, Westfeld M, Braun M, Zivanovic O, Schink T, Kuhn W, et al. Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer. 2012;20:2669–77.

    Article  PubMed  PubMed Central  Google Scholar 

  19. McKee M, Frei BL, Garcia A, Fike D, Soefje SA. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic. J Oncol Pharm Pract. 2011;17(4):387–94.

    Article  PubMed  Google Scholar 

  20. Ibrahim NA, Björnsdottir I, Al Alwan AS, Honore PH. Insights about health related quality of life indicate demands for better pharmaceutical care. J Oncol Pharm Pract. 2014;20(4):270–7.

    Article  Google Scholar 

  21. Silpakit C, Sirilerttrakul S, Jirajarus M, Sirisinha T, Ekaphop S, Ratanatharathorn V. The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ– C30): validation study of the Thai version. Qual Life Res. 2006;15:167–72.

    Article  PubMed  Google Scholar 

  22. Kawaguchi T, Iwase S, Koinuma M, Onodera Y, Takeuchi H, Umeda M, et al. Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan. Biol Pharm Bull. 2012;35(1):59–64.

    Article  CAS  PubMed  Google Scholar 

  23. Touchette DR, Doloresco F, Suda KJ, Perez A, Turner S, Jalundhwala Y, et al. Economic evaluations of clinical pharmacy services: 2006–2010. Pharmacotherapy. 2014;34(8):771–93.

    Article  PubMed  Google Scholar 

  24. Leveque D, Delpeuch A, Gourieux B. New anticancer agents: role of clinical pharmacy services. Anticancer Res. 2014;34(4):1573–8.

    CAS  PubMed  Google Scholar 

  25. Delpeuch A, Leveque D, Gourieux B, Herbrecht R. Impact of clinical pharmacy services in a hematology/oncology inpatient setting. Anticancer Res. 2015;35(1):457–60.

    PubMed  Google Scholar 

  26. Khanal S, Poudel A, Sharan K, Palaian S. Oncology pharmacy practice in a teaching hospital in Nepal. J Oncol Pharm Pract. 2010;16(2):75–9.

    Article  PubMed  Google Scholar 

  27. Walter C, Mellor JD, Rice C, Kirsa S, Ball D, Duffy M, et al. Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic. Asia Pac J Clin Oncol. 2014. doi:10.1111/ajco.12267.

    PubMed  Google Scholar 

  28. Felton MA, van Londen G, Marcum ZA. Medication adherence to oral cancer therapy: the promising role of the pharmacist. J Oncol Pharm Pract. 2016;22(2):378–81.

    Article  PubMed  Google Scholar 

  29. Coutsouvelis J, Corallo CE, Dooley MJ, Foo J, Whitfield A. Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units. Support Care Cancer. 2010;18(7):811–6.

    Article  PubMed  Google Scholar 

  30. Katayama S. The role in cancer chemotherapy of “a pharmacist specialized in cancer”. Gan To Kagaku Ryoho. 2006;33(11):1575–8.

    PubMed  Google Scholar 

  31. Tuffaha HW, Koopmans SM. Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. J Oncol Pharm Pract. 2012;18(2):180–5.

    Article  PubMed  Google Scholar 

  32. Inoue T. Management of pharmacists on the cancer chemotherapy. Gan To Kagaku Ryoho. 2004;31(1):11–6.

    PubMed  Google Scholar 

  33. Chan A, Tan SH, Wong CM, Yap KY, Ko Y. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists. Clin Ther. 2009;31(Pt 2):2379–86.

    Article  CAS  PubMed  Google Scholar 

  34. Arunachalam D, Thirumoorthy A, Devi S. Thennarasu. Quality of life in cancer patients with disfigurement due to cancer and its treatments. Indian J Pallait Care. 2011;17(3):184–90.

    Article  Google Scholar 

  35. Richardson T, O’Reilly C, Chen TF. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm. 2014;36:222–32.

    Article  PubMed  Google Scholar 

  36. Norrström B, Cannerfelt IB, Frid H, Roos K, Ramström H. Introduction of pharmaceutical expertise in a palliative care team in Sweden. Pharm World Sci. 2010;32(6):829–34.

    Article  PubMed  Google Scholar 

  37. Mousavi M, Hayatshahi A, Sarayani A, Hadjibabaie M, Javadi M, Torkamandi H, et al. Impact of clinical pharmacist based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer. 2013;21:3441–8.

    Article  PubMed  Google Scholar 

  38. Ryan N, Chambers C, Ralph C, England D, Cusano F. Evaluation of clinical pharmacists follow up service in an oncology pain clinic. J Oncol Pharm Pract. 2012;19(2):151–8.

    Article  PubMed  Google Scholar 

  39. Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006;40(9):1527–33.

    Article  PubMed  Google Scholar 

  40. Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, et al. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011;68(7):613–9.

    Article  PubMed  Google Scholar 

  41. Ruder AD, Smith DL, Madsen MT, Kass FH. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011;17(4):425–32.

    Article  PubMed  Google Scholar 

  42. Chew C, Chiang J, Yeoh TT. Impact of outpatient interventions made at an ambulatory cancer centre oncology pharmacy in Singapore. J Oncol Pharm Pract. 2015;21(2):93–101.

    Article  PubMed  Google Scholar 

  43. Van Den Broucke J, Verhaeghe A, Debruyne PR, Verhelle K. Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients. J Pharm Belg. 2014;1:28–36.

    Google Scholar 

  44. Ishimoto K, Otsubo Y, Tamura C, Uchida Y, Ishimitsu T, Kamiya A. The role of pharmacists for promotion of cancer chemotherapy in outpatients. Yakugaku Zasshi. 2004;124(3):149–57.

    Article  CAS  PubMed  Google Scholar 

  45. Koshita A, Nishiwaki M, Hirashima Y, Idosawa H, Lioka K, Ichikawa Y. Role of pharmacists in providing outpatient clinic cancer chemotherapy—a current status of Tokyo Metropolitan Komagome Hospital. Gan To Kagaku Ryoho. 2007;34(Suppl 2):257–9.

    PubMed  Google Scholar 

  46. Iihara H, Ishihara M, Matsuura K, Kurahashi S, Takahashi T, Kawaguchi M, et al. Pharmacists contribute to the improved efficiency of medical practises in the outpatient cancer chemotherapy clinic. J Eval Clin Pract. 2012;18:753–60.

    Article  PubMed  Google Scholar 

  47. Paul M, Davey B, Senf B, Stoll C, Münstedt K, Mücke R, et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol. 2013;139:1515–22.

    Article  PubMed  Google Scholar 

  48. de Lemos ML. Pharmacist’s role in meeting the psychosocial needs of cancer patients using complementary therapy. Psycho–Oncology. 2005;14:204–10.

    Article  PubMed  Google Scholar 

  49. Atayee RS, Best BM, Daniels CE. Development of an ambulatory palliative care pharmacist practice. J Palliat Med. 2008;11(8):1077–82.

    Article  PubMed  Google Scholar 

  50. Smith MB, Gumpper KF, Riebandt G, Handel EM. Implementation of the pharmacy practice model initiative within comprehensive cancer centers. Am J Health Syst Pharm. 2014;71(19):1647–60.

    Article  PubMed  Google Scholar 

  51. Edwards SJ, Abbott R, Edwards J, LeBlanc M, Dranitsaris G, Donnan J, et al. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic. J Pharm Pract. 2014;27(1):46–52.

    Article  PubMed  Google Scholar 

  52. Lopez-Martin C, Garrido Siles M, Alcaide-Garcia J, Faus Felipe V. Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience. Int J Clin Pharm. 2014;36(6):1251–9.

    Article  PubMed  Google Scholar 

  53. Shamieh O, Hui D. A comprehensive palliative care program at a tertiary cancer center in Jordan. Am J Hosp Palliat Care. 2015;32(2):238–42.

    Article  PubMed  Google Scholar 

  54. Gagnon L, Fairchild A, Pituskin E, Dutka J, Chambers C. Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist. J Oncol Pharm Pract. 2012;18(1):76–83.

    Article  CAS  PubMed  Google Scholar 

  55. Tralongo P, Ferrau F, Borsellino N, Verderame F, Caruso M, Giuffrida D, et al. Cancer patient-centered home care: a new model for health care in oncology. Ther Clin Risk Manag. 2011;7:387–92.

    PubMed  PubMed Central  Google Scholar 

  56. Tait PA, Gray J, Hakendorf P, Morris B, Currow DC, Rowett DS. Community pharmacists: a forgotten resource for palliative care. BMJ Support Palliat Care. 2013;3(4):436–43.

    Article  PubMed  Google Scholar 

  57. O’Connor M, Hewitt LY, Tuffin PH. Community pharmacists’ attitudes toward palliative care: an Australian nationwide survey. J Palliat Med. 2013;16(12):1575–81.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Kato T. The role of home palliative care by health insurance pharmacy. Gan To Kagaku Ryoho. 2011;38(Suppl 1):56–8.

    PubMed  Google Scholar 

  59. Hussainy SY, Beattie J, Nation RL, Dooley MJ, Fleming J, Wein S, et al. Palliative care for patients with cancer: what are the educational needs of community pharmacists? Support Care Cancer. 2006;14(2):177–84.

    Article  PubMed  Google Scholar 

  60. Akai N, Fujita-Hamabe W, Tokuyama S. Attitude survey of medical staff on the participation of community pharmacists in palliative home care. Yakugaku Zasshi. 2009;129(11):1393–401.

    Article  CAS  PubMed  Google Scholar 

  61. Hussainy SY, Marriott JL, Beattie J, Nation RL, Dooley MJ. A palliative cancer care flexible education program for Australian community pharmacists. Am J Pharm Educ. 2010;74(2):24.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Savage I, Blenkinsopp A, Closs SJ, Bennett MI. ‘Like doing a jigsaw with half the parts missing’: community pharmacists and the management of cancer pain in the community. Int J Pharm Pract. 2013;21(3):151–60.

    Article  PubMed  Google Scholar 

  63. O’Connor M, Pugh J, Jiwa M, Hughes J, Fisher C. The palliative care interdisciplinary team: where is the community pharmacist? J Palliat Med. 2011;14(1):7–11.

    Article  PubMed  Google Scholar 

  64. Takagi M. Pharmacists in community medicine: especially in cancer treatment. Yakugaku Zasshi. 2011;131(1):45–9.

    Article  CAS  PubMed  Google Scholar 

  65. Satoh H, Miki A, Maejima K, Iizuka K, Yamaga S, Sakashita K, et al. Problems of collaboration between community and hospital pharmacists for cancer chemotherapy and proposed corrective measures: KJ method based identification and planning workshop. Yakugaku Zasshi. 2014;134(4):563–74.

    Article  CAS  PubMed  Google Scholar 

  66. Katori C, Tamura Y, Nishimura K, Karasawa J, Kushida K. The role of pharmacists involved in drug therapy for home-care patients with the end-stage cancer. Gan to kagaku ryoho. Cancer Chemother. 2007;34(2):232–5.

    Google Scholar 

  67. Suzuki M, Sato M, Okazawa M, Sakata S, Orii T. Benefits of pharmacists’ assessment of outpatients undergoing Chemotherapy. Gan To Kagaku Ryoho. 2010;37(13):2881–5.

    PubMed  Google Scholar 

  68. Needham DS, Wong IC, Campion PD, Hull and east riding pharmacy development group. Evaluation of the effectiveness of UK community pharmacists’ interventions in community palliative care. Palliat Med. 2002;16(3):219–25.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to express our thanks to Dr. Denes Kleiner for supporting the outcome search.

Funding

There were no sources of funding or other support for this systematic review.

Author information

Authors and Affiliations

  1. University Pharmacy Department of Pharmacy Administration, Semmelweis University, Street 7-9, Hogyes E, Budapest, 1092, Hungary

    Johannes Thoma, Romána Zelkó & Balázs Hankó

Authors
  1. Johannes Thoma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Romána Zelkó
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Balázs Hankó
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Romána Zelkó.

Ethics declarations

Conflicts of interest

The authors have no conflicts of interest—financial or otherwise—to report.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 6926 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thoma, J., Zelkó, R. & Hankó, B. The need for community pharmacists in oncology outpatient care: a systematic review. Int J Clin Pharm 38, 855–862 (2016). https://doi.org/10.1007/s11096-016-0297-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-016-0297-2

Keywords

Search

Navigation